Equities

WAVE Life Sciences Ltd

WAVE Life Sciences Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)15.89
  • Today's Change-0.55 / -3.35%
  • Shares traded1.90m
  • 1 Year change+202.67%
  • Beta-1.1960
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year WAVE Life Sciences Ltd grew revenues 3,005.10% from 3.65m to 113.31m while net income improved from a loss of 161.82m to a smaller loss of 57.51m.
Gross margin--
Net profit margin-66.50%
Operating margin-75.74%
Return on assets-33.49%
Return on equity--
Return on investment-117.16%
More ▼

Cash flow in USDView more

In 2023, WAVE Life Sciences Ltd increased its cash reserves by 121.42%, or 111.89m. Cash Flow from Financing totalled 132.53m or 116.97% of revenues. In addition the company used 19.43m for operations while cash used for investing totalled 1.12m.
Cash flow per share-0.5805
Price/Cash flow per share--
Book value per share0.0359
Tangible book value per share0.0359
More ▼

Balance sheet in USDView more

WAVE Life Sciences Ltd uses little or no debt in its capital structure.
Current ratio0.9939
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.